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Abstract Older people often suffer from multiple dis-
eases. Therefore, universal cross-disease outcomes (e.g.
functional status, quality of life, overall survival) are more
relevant than disease-specific outcomes, and a range of
potential outcomes are needed for medical decision-mak-
ing. To assess how patient-relevant outcomes have
penetrated randomized controlled trials (RCTs), reporting
of these outcomes was reviewed in heart failure trials that
included patients with multimorbidity. We systematically
reviewed RCTs (Jan 2011–June 2012) and evaluated re-
ported outcomes. Heart failure was chosen as condition of
interest as this is common among older patients with
multimorbidity. The main outcome was the proportion of
RCTs reporting all-cause mortality, all-cause hospital ad-
mission, and outcomes in four domains of health, i.e.
functional, signs and symptoms, psychological, and social
domains. Of the 106 included RCTs, 50 (47 %) reported
all-cause mortality and cardiovascular mortality and 29
(27 %) reported all-cause hospitalization and cardiovas-
cular hospitalization. Of all trials, 68 (64 %) measured
outcomes in the functional domain, 80 (75 %) in the do-
main of signs and symptoms, 65 (61 %) in the psycho-
logical domain, and 59 (56 %) in the social domain.
Disease-specific instruments were more often used than
non-disease-specific instruments. This review shows in-
creasing attention for more patient-relevant outcomes; this
is promising and indicates more awareness of the impor-
tance of a variety of outcomes desirable for patients.
However, patients’ individual goal attainments were uni-
versally absent. For continued progress in patient-centred
care, efforts are needed to develop these outcomes, study
their merits and pitfalls, and intensify their use in research.
Keywords Heart failure  Patient-reported outcomes 
Patient-centred  Multimorbidity
Introduction
Clinical decisions in the management of chronic diseases
are usually guided by disease-specific targets, such as
symptom control, prevention of impaired organ function,
achievement of targeted laboratory parameters, or disease-
specific survival. However, in older people who often
suffer from multiple diseases, universal cross-disease out-
comes, such as functional status, quality of life (QoL), or
overall survival, are more relevant, as different diseases
and treatments may interact and a range of potential out-
comes (desired and undesired) have to be taken into ac-
count in medical decision-making [1–3]. Improving the
disease-specific outcomes of one disease may not prevent
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deterioration of outcomes of another disease, which can be
more harmful and stressful to the patient [4]. Therefore,
universal outcomes become more important and relevant to
patients with multiple conditions. However, the same does
not seem to apply to the research community, which gen-
erally remains focused on uni-dimensional disease-specific
and often surrogate outcomes [5, 6] that may have little
impact in the everyday lives of patients.
Older people can develop their own individual prefer-
ences for what treatment of their chronic disease(s) should
achieve. For instance, daily functioning can become more
important than survival or maintaining independence more
important than prevention of disease [7].This has been
taken into consideration in patient-centred care. Patient-
centred care is respectful of and responsive to individual
patient preferences, needs, and values. These patient values
are integrated in good clinical decisions [8, 9]. Therefore,
in patient-centred care, clinicians need to identify their
patients’ preferred or priority outcomes in various domains
of health on an ongoing basis and adjust their therapy
accordingly.
To facilitate evidence-based clinical decision-making in
patient-centred care, ideally outcomes should therefore be
goal-oriented, specifying patients’ own individual goals
[7]. Currently, however, the use of measures such as goal
attainment scales is mainly restricted to rehabilitation
medicine [10, 11]. As long as individual goal attainment
remains difficult to measure, research should provide
clinicians with a range of disease-specific as well as non-
disease-specific patient-relevant outcomes (i.e. outcomes
that are meaningful to patients), and estimate or discuss the
associations between them [12]. This will enable clinicians
to focus on improving functional status when this is the
patient’s preference, or on improving survival when this
meets the patient’s priority. Evidence to support such de-
cisions, especially in patients with multiple diseases, is
sparse. We hypothesize that, although patient-relevant
outcomes such as all-cause mortality are used in research,
patient-relevant outcomes in other domains of health and
wellbeing are underrepresented. Apart from outcomes on
all-cause hospital admission and survival, patient-relevant
outcomes in other domains of health are of interest. These
can be classified into five dimensions: functional (activities
of daily living), somatic (signs and symptoms), psycho-
logical, social, and communicative. This classification was
developed in rehabilitation medicine and has been applied
extensively in Dutch nursing home care [13].
In order to assess the range of reported outcomes and to
study whether patient-relevant outcomes in a variety of
health domains have been measured by randomized con-
trolled trials (RCTs), we reviewed the reporting of patient-
relevant (cross-disease) outcomes in RCTs that included
patients with chronic heart failure. We chose this condition
as a model, as patients with heart failure are generally older




To examine which patient-relevant outcomes are reported
in RCTs in patients with chronic heart failure, RCTs
published from 1 January 2011 to 1 June 2012 were re-
viewed and the reported outcomes were evaluated.
Search strategy
The search for RCTs was performed by an expert librarian.
PubMedwas searched forRCTs on patientswith heart failure
using the following search strategy: (‘‘heart failure’’[Major]
OR ‘‘heart failure’’[ti] OR ‘‘Cardiac Failure’’[ti] OR ‘‘My-
ocardial Failure’’[ti] OR ‘‘Heart Decompensation’’[ti]) AND
(‘‘Randomized Controlled Trial’’[Publication Type] OR
‘‘Randomized Controlled Trial’’[ti] OR ‘‘RCT’’[ti] OR
‘‘Controlled Clinical Trial’’[Publication Type] OR ran-
domized[ti] OR randomised[ti] OR placebo[ti] OR ran-
domly[ti] OR trial[ti]).
Eligibility criteria
Studies were eligible if they reported a phase 3 or 4 RCT in
adult patients with chronic or acute heart failure. Studies
reporting only subgroup analysis of an RCT were excluded.
No limitations on interventions, patient groups, or language
were applied. RCTs were not excluded on the basis of
methodological quality of the study.
Screening and data extraction
RCTs were selected independently by two authors (JB,
ME) by screening title and abstract and full article if
necessary. Any discrepancies were resolved by consensus
with a third author (MVD). Two researchers independently
extracted information (BV, ME). In the case of disagree-
ment on extracted data, consensus was reached by discus-
sion with a third author (JB).
Variables collected were as follows: sample size, inter-
vention and control group, mean age, proportion of male
subjects, excluded and registered co-morbidity, and asses-
sed outcomes (primary outcomes, as well as secondary
outcomes). The data were extracted into pre-specified
tables.
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Categorizing of outcomes used in the studies
In accordance with the aim to review a diversity of patient-
relevant outcomes, we defined the outcomes of interest as
follows: all-cause mortality, all-cause hospital admission,
and disease-specific and non-specific outcomes represent-
ing the Bangma domains [13]. These domains represent 5
domains of health: functional (activities of daily living),
somatic (signs and symptoms), psychological, social, and
communicative. We combined the social and communica-
tive domain into one domain. This classification has been
developed in rehabilitation medicine and has been applied
extensively in Dutch nursing home medicine. It is an aid to
cover all health domains while making an inventory of
existing problems relevant to the patient. The patient-
relevant outcomes could be self-reported (e.g. QoL ques-
tionnaires or self-reported symptoms) or could be observed
(e.g. the 6-m walking test, or NYHA class). Other reported
outcomes concerning caregivers, costs, perception of care,
self-care or care knowledge, and surrogate outcomes such
as biomarkers or intermediate outcomes (e.g. ejection
fraction measured by echocardiography) were not anal-
ysed. In addition to the above-mentioned outcomes of in-
terest, we also checked whether goal-oriented outcomes
were used. As goal-oriented outcomes, we considered
outcomes that took into account patient’s preferences, such
as the achievement of individually agreed health care goals
(e.g. goal attainment scales).
The reported outcomes were scrutinized to examine
their coverage of the Bangma domains [13] by two re-
searchers (BdV, ME). Per instrument, each of the items/
questions was allocated to a certain Bangma domain by
two researchers independently. The social and commu-
nicative domain was aggregated as a social domain. The
psychological domain concerned psychological and cog-
nitive issues. Disagreement was resolved in discussion with
a third author (JB).
The main outcome was the proportion of RCTs report-
ing all-cause mortality, all-cause hospital admission, and
outcomes in the Bangma domains (functional, signs and
symptoms, psychological, and social).
No distinction was made between primary and sec-
ondary outcomes as reported in the studies, as we did not
aim to synthesize the data quantitatively.
Data analysis
The number and percentage of studies using outcome
measures in the above-mentioned dimensions are
described.
As QoL measures were often used and cover all di-
mensions, we first tabulate QoL measures (disease-specific
and non-specific) and subsequently other outcome
measures covering at least one dimension (disease-specific
and non-specific).
Results
Characteristics of the included studies
Figure 1 shows the selection of the 106 RCTs included in
this review, and Table 1 summarizes the characteristics. Of
all included trials, 77 (73 %) had a population of C50
patients, of which 60 trials had a population of C100 pa-
tients. Of all trials, 29 % concerned drug interventions and
the remainder investigated non-drug interventions (e.g.
exercise and diet) or health service interventions. Most
trials (72 %) included patients from all NYHA classes.
Reported outcomes in heart failure RCTs
A total of 50 (47 %) trials reported all-cause and cardio-
vascular mortality, 12 (11 %) reported only all-cause
mortality, and 5 (5 %) only cardiovascular mortality. For
hospitalization, this was 29 (27 %) for all-cause and car-
diovascular, 3 (3 %) for only all-cause, and 26 (25 %) for
only cardiovascular hospitalization.
A total of 68 (64 %) trials studied outcomes in the
functional domain, 80 (75 %) in the domain of signs and
symptoms, 65 (61 %) in the psychological domain, and 59
(56 %) in the social domain. For the group of drug trials
this was 39, 74, 39, and 32 % respectively, for health
service interventions this was 67, 67, 63, and 56 %, and for
the remaining non-drug trials this was 79, 81, 75 and 71 %.
No goal-oriented outcomes were used in any of the studies.
Papers selected based 
on title and abstract
n=557
Papers excluded based on title and abstract
n=451
- Not an RCT n=110
- Pilot study n=20
- Double publication or
subgroup analysis n=129
- Non-heart failure patients n=50
- Phase 1 or 2 of trial n=82
- Design/protocol n=41
- Correspondence n=17
- Not obtainable n=2
Papers included
n=106
Papers selected with 
search strategy in 
Pubmed n=2848
Fig. 1 Inclusion of the studies
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In three RCTs (3 %), only surrogate outcomes (e.g.
cardiopulmonary exercise tests, blood pressure, pulse rate,
ECGs, pro-BNP and other biomarkers) were reported.
Outcome instruments used
In total, 60 (57 %) trials used QoL instruments; 9 studies
used two QoL outcomes, and two studies used three QoL
outcomes. Disease-specific QoL instruments were applied
more than twice as often as non-disease-specific instru-
ments: 48 (45 %) versus 22 (21 %) trials. Of the instru-
ments other than QoL, in 51 (48 %) trials disease-specific
instruments for outcome measurement were used and in 38
(36 %) trials non-disease-specific instruments were used.
Table 2 provides an overview of the instruments used in
more than one study and covering all Bangma domains.
QoL scales contain items on all Bangma domains.
Other disease-specific and non-specific patient-relevant
outcomes relating to one or more of the domains which
were used in a single study only (and not included in
Table 2) were as follows: various outcomes for depressive
symptoms or cognition (n = 9 trials), various outcomes for
activity or energy expenditure (n = 5 trials), outcomes for
heart failure symptoms (n = 4 trials), outcomes related to
sleep quality (n = 3 trials), outcomes measuring treatment
satisfaction (n = 2 trials), and outcomes related to patients’
perception of control over their condition (n = 1 trial).
Discussion
Main findings
In this review of heart failure RCTs, we found a relatively
broad range of potentially patient-relevant outcomes ad-
dressing mortality, hospitalization, and outcomes in the
Bangma health domains. This finding is promising and may
demonstrate an awareness of the importance of a variety of
outcomes that are desirable for patients. However, none of
the trials reported goal attainment in accordance with pa-
tients’ individual preferences. Whereas all-cause mortality
and hospitalization were more frequently measured than
their disease-specific counterparts, the majority of patient-
reported outcomes measured were still based on disease-
Table 1 Characteristics of the trials (n = 106), reporting of comorbidity, and exclusion based on comorbidity
No. of studies (%)
Mean age in years (range)a 67.6 (37.2–80.4)
Proportion of male subjectsa 66.7
Chronic heart failure 98 (92)
Type of intervention
Drug intervention 31 (29)
Non-drug intervention (e.g. surgery, exercise and dietary interventions) 48 (45)
Health service intervention (e.g. nurse-led (tele)monitoring, multidisciplinary monitoring,
education on CHF management)
27 (26)
Sample size median (IQR) 111 (46–265)
NYHA classification used in inclusion
Only I–II 3 (3)
Only II–III 22 (21)
Only III–IV 5 (5)
All 76 (72)
Excluded conditions
Diabetes mellitus 12 (11)
Hypertension 10 (9)
Other cardiovascular disease including dyslipidaemia 71 (67)
Other non-cardiovascular disease 72 (68)
Type of conditions reported
Diabetes mellitus 63 (59)
Hypertension 58 (55)
Other cardiovascular disease including dyslipidaemia 58 (55)
Other non-cardiovascular disease 42 (40)
a Calculated over all studies
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specific instruments. Almost two-thirds of the trials studied
outcomes in at least one of the four domains of health (i.e.
functional domain, domain of signs and symptoms, psy-
chological domain, or social domain): of these, signs and
symptoms were by far the most investigated, and func-
tioning and the psychological and social domains were the
least investigated. Remarkably, non-drug trials used other
patient-relevant outcomes than signs and symptoms about
twice as often than drug trials.
Although many of the trials applied QoL instruments
that cover most or all domains to some extent, the
aggregation of different domains in a sum score hampers a
differentiated conclusion to inform medical decision-
making. Nevertheless, it has been argued that QoL mea-
sures should be used more often in heart failure trials [15,
16] in order to incorporate outcomes that are relevant to
patients, in addition to mortality and hospital admission.
However, Gill et al. [17] argue that QoL measures do not
include patients’ opinions and reactions and therefore do
not aim at the correct target; this conclusion was confirmed
by Dunderdale et al. [18]. Most of the QoL instruments are
not patient-centred and restrict the patient’s choice by
Table 2 Instruments used in
more than one study and
covering the Bangma domains
MLHFQ minnesota living with
heart failure questionnaire [30],
KCCQ Kansas City
cardiomyopathy questionnaire
[31], McNew McNew QoL after
myocardial infarction
questionnaire [32], SF short-
form 12 and 36 [33], EQ5D
Euro quality-of-life 5D [34],
AQoL assessment quality of life
[35], NYHA New York Heart
Association, VAS visual
analogue scale, HFSS heart
failure symptom scale [36],
6MWT six-minute walking test
[37], RPE rating of perceived
exertion [38], BDI Beck’s
depression inventory [39],










MLHFQ 45 (39) dyspnoea, 
swelling, fatigue
KCCQ   4 (4) dyspnoea, 
swelling, fatigue
MacNew 2 (2) pain
Other
6MWT 29 (27)





SF-36 11 (10) pain
EQ-5D 5 (5) pain
SF-12 4 (4) pain
SIP 2 (2)
AQol 1 (1) pain
Other





11 (10) dyspnoea, cough, 
oedema, sleep
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imposing standard models of QoL and preselected domains
on the individual. Furthermore, QoL instruments have
mainly been developed and validated in younger popula-
tions and tend to be phrased mainly in relation to physical
function, thus underestimating QoL in older persons whose
physical function is likely to be not as good as that of
younger people [19]. QoL of older people (e.g. most pa-
tients with chronic heart failure) is considered a multidi-
mensional construct that includes objective indicators and
subjective evaluations related to developmental processes
of growth, maintenance, and resilience, as well as man-
agement of loss, which have not been adopted by the QoL
instruments used in the RCTs included in this review [20].
In the reviewed trials, important specific outcomes (e.g.
dyspnoea, oedema and fatigue) were mainly evaluated by
the QoL questionnaires used; however, this method of
evaluating heart failure outcomes is reported to be inade-
quate [21]. In addition, pain is generally not included in
heart failure-specific QoL measures, as it is not a symptom
caused by heart failure. Nevertheless, pain is very common
in heart failure patients due to the high prevalence of
(painful) comorbidities [22]. Another disadvantage of (in
particular) disease-specific QoL instruments is that the
questions relate to the disease under study, in this case
heart failure. For example, a question about depressive
feelings links these feelings to heart failure: ‘Did your
heart failure prevent you from living as you wanted during
the past month (4 weeks) by making you feel depressed?’ In
this way, general feelings of depression unrelated to heart
failure might be missed [23].
To the best of our knowledge, this is the first study to
classify outcomes into patient-relevant domains of health.
We used the Bangma criteria that provide a holistic
framework that has been used and validated in rehabilita-
tion medicine. The Bangma model [13] is designed to
support problem-based care as opposed to disease-oriented
care and lists all clinically relevant problem areas of the
patient: activities of daily living, signs and symptoms,
psychological, social, and communicative domains. This
model is similar to the composite measure recommended
by the National Institute on Aging to monitor the health of
older people with multiple chronic conditions [5].
Strengths and limitations
We used Pubmed to select a systematic sample of RCTs
over a certain period of time that included patients with
heart failure and multiple diseases. Some RCTs might have
been missed by not searching other databases such as
Embase or Web of Science. However, our aim was not to
conduct an exhaustive overview of RCTs including heart
failure patients, but rather to capture a large sample of such
studies. A strength of our study is that all selection and data
extraction was conducted by two reviewers independently,
which reduces the risk of bias.
In this review, although the attention paid tomore patient-
relevant outcomes is promising, this finding may be influ-
enced by the choice of the primary condition.We chose heart
failure as it is a common condition in older patients with
multimorbidity. The association between heart failure and
multimorbidity was reported more than a decade ago [14],
and therefore, recent heart failure guidelines address multi-
morbidity more often than the guidelines for other diseases
[24]. For these reasons, our results may be overly optimistic
when applied to other chronic diseases where the debate
about multimorbidity is still relatively young and may not
have influenced the choice of outcomes in research.
Conclusion and implications
Although an encouragingly high proportion of heart fail-
ure trials report patient-relevant outcomes, patients’ indi-
vidual goal attainments were universally absent from all
the trials included in this review. In practice, clinicians
negotiate clinical management with their patients usually
taking their individual preferences into account. However,
in research we are still far from giving individual goals a
priority. Some research groups have developed patient-
reported outcomes that include patients’ goals [25–28].
However, their feasibility and completeness, especially
for research purposes, is still suboptimal [29]. To make
progress in patient-centred care, more studies are needed
to further develop these outcomes, examine their merits
and pitfalls, and intensify their use in research. Patients
need to be centrally involved in the design, development,
and testing of such goal-orientated outcome research
methods.
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